406 related articles for article (PubMed ID: 8658503)
1. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes.
Camus-Randon AM; Raffalli F; Béréziat JC; McGregor D; Konstandi M; Lang MA
Toxicol Appl Pharmacol; 1996 May; 138(1):140-8. PubMed ID: 8658503
[TBL] [Abstract][Full Text] [Related]
2. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
[TBL] [Abstract][Full Text] [Related]
3. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
Su T; He W; Gu J; Lipinskas TW; Ding X
Drug Metab Dispos; 1998 Aug; 26(8):822-4. PubMed ID: 9698299
[TBL] [Abstract][Full Text] [Related]
4. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
5. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.
Pinto LF; Moraes E; Albano RM; Silva MC; Godoy W; Glisovic T; Lang MA
Carcinogenesis; 2001 Nov; 22(11):1877-83. PubMed ID: 11698352
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.
Salonpää P; Krause K; Pelkonen O; Raunio H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):446-52. PubMed ID: 7543189
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism.
Béréziat JC; Raffalli F; Schmezer P; Frei E; Geneste O; Lang MA
Mol Carcinog; 1995 Oct; 14(2):130-9. PubMed ID: 7576100
[TBL] [Abstract][Full Text] [Related]
8. The role of stress in the regulation of drug metabolizing enzymes in mice.
Konstandi M; Marselos M; Radon-Camus AM; Johnson E; Lang MA
Eur J Drug Metab Pharmacokinet; 1998; 23(4):483-90. PubMed ID: 10323331
[TBL] [Abstract][Full Text] [Related]
9. Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus.
Chomarat P; Sipowicz MA; Diwan BA; Fornwald LW; Awasthi YC; Anver MR; Rice JM; Anderson LM; Wild CP
Carcinogenesis; 1997 Nov; 18(11):2179-90. PubMed ID: 9395219
[TBL] [Abstract][Full Text] [Related]
10. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.
Gilmore WJ; Hartmann G; Piquette-Miller M; Marriott J; Kirby GM
Toxicology; 2003 Mar; 184(2-3):211-26. PubMed ID: 12499123
[TBL] [Abstract][Full Text] [Related]
11. High expression of cytochrome P450 2a-5 (coumarin 7-hydroxylase) in mouse hepatomas.
Kobliakov V; Kulikova L; Samoilov D; Lang MA
Mol Carcinog; 1993; 7(4):276-80. PubMed ID: 8352886
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver.
De-Oliveira AC; Da-Matta AC; Paumgartten FJ
Exp Parasitol; 2006 Aug; 113(4):256-61. PubMed ID: 16540109
[TBL] [Abstract][Full Text] [Related]
13. cAMP mediated upregulation of CYP2A5 in mouse hepatocytes.
Viitala P; Posti K; Lindfors A; Pelkonen O; Raunio H
Biochem Biophys Res Commun; 2001 Jan; 280(3):761-7. PubMed ID: 11162586
[TBL] [Abstract][Full Text] [Related]
14. Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.
Hahnemann B; Salonpää P; Pasanen M; Mäenpää J; Honkakoski P; Juvonen R; Lang MA; Pelkonen O; Raunio H
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):289-94. PubMed ID: 1520280
[TBL] [Abstract][Full Text] [Related]
15. Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.
Salonpää P; Iscan M; Pasanen M; Arvela P; Pelkonen O; Raunio H
Biochem Pharmacol; 1992 Oct; 44(7):1269-74. PubMed ID: 1417950
[TBL] [Abstract][Full Text] [Related]
16. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
Sheweita SA
Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma.
Raunio H; Juvonen R; Pasanen M; Pelkonen O; Pääkkö P; Soini Y
Hepatology; 1998 Feb; 27(2):427-32. PubMed ID: 9462641
[TBL] [Abstract][Full Text] [Related]
18. Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse.
Pellinen P; Stenbäck F; Raunio H; Pelkonen O; Pasanen M
Eur J Pharmacol; 1994 Nov; 292(1):57-65. PubMed ID: 7867690
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.
Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
Mol Carcinog; 1998 Aug; 22(4):229-34. PubMed ID: 9726815
[TBL] [Abstract][Full Text] [Related]
20. Acute sodium arsenite treatment induces Cyp2a5 but not Cyp1a1 in the C57Bl/6 mouse in a tissue (kidney) selective manner.
Seubert JM; Webb CD; Bend JR
J Biochem Mol Toxicol; 2002; 16(2):96-106. PubMed ID: 11979426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
